EANS-Adhoc: CURANUM AG / quaterly figures

ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement.


The Curanum Group´s first-quarter revenue was up by EUR 1.6 million year-to-year to reach
EUR 64 million The increase was mainly due to the start-up of the new care home in Wachtendonk and also reflects a slightly higher occupancy rate. Operating EBITDA of EUR 6.1 million were slightly below the previous year´s result of EUR 6.3 million. The EUR 6.1 million earnings of the first quarterly period include one-off effects of consultancy expenses for the company´s capital increase and refinancing in order to implement the notified expansion strategy. The first-quarter net financial result stood at EUR -2.4 million, representing EUR 0.3 million decline. This year-on-year reduction is mainly attributable to higher interest expenses connected with new finance leases. Consequently, first-quarter earnings after tax amounted to EUR 0.5 million. This represents a decrease by EUR 0.6 million compared to last year´s result.

The present interim CEO Walther Wever will be at Curanum AG´s disposal beyond June 30th 2011, until a successor is found who will continue the strategic reorientation.

end of announcement euro adhoc

issuer: CURANUM AG Engelbertstraße 23-25 D-81241 München phone: +49 (0)89 242065 0 FAX: +49 (0) 89 242065 10 mail: info@curanum.de WWW: http://www.curanum.de sector: Healthcare Providers ISIN: DE0005240709 indexes: CDAX, Classic All Share, Prime All Share

stockmarkets: regulated dealing/prime standard: Frankfurt, free trade: Berlin, Hamburg, Stuttgart, Düsseldorf, regulated dealing: München language: English

Rückfragen & Kontakt:

Caroline Lutz
Tel.: + 49 89 242065 17
E-Mail: ir@curanum.de